Menu Search
Equities

GN Store Nord A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GN:CPH

GN Store Nord A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)100.05
  • Today's Change-0.05 / -0.05%
  • Shares traded733.79k
  • 1 Year change-43.10%
  • Beta0.9308
Data delayed at least 15 minutes, as of Jul 18 2025 15:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 17-Apr-25
  • 15-May-25
  • 19-Jun-25
  • 17-Jul-25
Select bar for recommendation details.
Recommendations17-Jul-25
Buy4
Outperform6
Hold7
Sell2
Strong Sell1

Share price forecast in DKK

The 18 analysts offering 12 month price targets for GN Store Nord A/S have a median target of 125.00, with a high estimate of 220.00 and a low estimate of 76.00. The median estimate represents a 24.88% increase from the last price of 100.10.
High119.8%220.00
Med24.9%125.00
Low-24.1%76.00

Dividends in DKK

Dividend information is not available for GN Store Nord A/S.
Div growth (TTM)--
More ▼

Earnings history & estimates in DKK

On Apr 30, 2025, GN Store Nord A/S reported 1st quarter 2025 earnings of 0.49 per share.
The next earnings announcement is expected on Aug 21, 2025.
Average growth rate+18.67%
GN Store Nord A/S reported annual 2024 earnings of 6.78 per share on Feb 06, 2025.
Average growth rate+56.04%
More ▼

Revenue history & estimates in DKK

GN Store Nord A/S had 1st quarter 2025 revenues of 3.99bn. This missed the 4.26bn consensus estimate of the 7 analysts following the company. This was 7.37% below the prior year's 1st quarter results.
Average growth rate-0.73%
GN Store Nord A/S had revenues for the full year 2024 of 17.99bn. This was 0.75% below the prior year's results.
Average growth rate+7.99%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.